trial · primary record
Artificial Tears Methylcellulose
Nasolacrimal Duct Obstruction
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Incidence of Post-Radiotherapy Nasolacrimal Duct Obstruction (NLDO) |
| Registry ID | NCT05999630 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:52.859Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05999630
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.